Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome

Noriko Miyake, Tomoki Kosho, Shuji Mizumoto, Tatsuya Furuichi, Atsushi Hatamochi, Yoji Nagashima, Eiichi Arai, Kazuo Takahashi, Rie Kawamura, Keiko Wakui, Jun Takahashi, Hiroyuki Kato, Hiroshi Yasui, Tadao Ishida, Hirofumi Ohashi, Gen Nishimura, Masaaki Shiina, Hirotomo Saitsu, Yoshinori Tsurusaki, Hiroshi DoiYoshimitsu Fukushima, Shiro Ikegawa, Shuhei Yamada, Kazuyuki Sugahara, Naomichi Matsumoto

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Ehlers-Danlos syndrome (EDS) is a heterogeneous connective tissue disorder involving skin and joint laxity and tissue fragility. A new type of EDS, similar to kyphoscoliosis type but without lysyl hydroxylase deficiency, has been investigated. We have identified a homozygous CHST14 (carbohydrate sulfotransferase 14) mutation in the two familial cases and compound heterozygous mutations in four sporadic cases. CHST14 encodes dermatan 4-O-sulfotransferase 1 (D4ST1), which transfers active sulfate from 3′-phosphoadenosine 5′-phosphosulfate to position 4 of the N-acetyl-Dgalactosamine (GalNAc) residues of dermatan sulfate (DS). Transfection experiments of mutants and enzyme assays using fibroblast lysates of patients showed the loss of D4ST1 activity. CHST14 mutations altered the glycosaminoglycan (GAG) components in patients' fibroblasts. Interestingly, DS of decorin proteoglycan, a key regulator of collagen fibril assembly, was completely lost and replaced by chondroitin sulfate (CS) in the patients' fibroblasts, leading to decreased flexibility of GAG chains. The loss of the decorin DS proteoglycan due to CHST14 mutations may preclude proper collagen bundle formation or maintenance of collagen bundles while the sizes and shapes of collagen fibrils are unchanged as observed in the patients' dermal tissues. These findings indicate the important role of decorin DS in the extracellular matrix and a novel pathomechanism in EDS.

Original languageEnglish
Pages (from-to)966-974
Number of pages9
JournalHuman Mutation
Volume31
Issue number8
DOIs
Publication statusPublished - 01-08-2010

Fingerprint

Ehlers-Danlos Syndrome
Decorin
Collagen
Dermatan Sulfate
Mutation
Fibroblasts
Glycosaminoglycans
2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine
Phosphoadenosine Phosphosulfate
Joint Instability
Skin
Chondroitin Sulfates
Enzyme Assays
Connective Tissue
Sulfates
Extracellular Matrix
Transfection
Maintenance
carbohydrate sulfotransferases
dermatan-4-sulfotransferase-1

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

Miyake, N., Kosho, T., Mizumoto, S., Furuichi, T., Hatamochi, A., Nagashima, Y., ... Matsumoto, N. (2010). Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome. Human Mutation, 31(8), 966-974. https://doi.org/10.1002/humu.21300
Miyake, Noriko ; Kosho, Tomoki ; Mizumoto, Shuji ; Furuichi, Tatsuya ; Hatamochi, Atsushi ; Nagashima, Yoji ; Arai, Eiichi ; Takahashi, Kazuo ; Kawamura, Rie ; Wakui, Keiko ; Takahashi, Jun ; Kato, Hiroyuki ; Yasui, Hiroshi ; Ishida, Tadao ; Ohashi, Hirofumi ; Nishimura, Gen ; Shiina, Masaaki ; Saitsu, Hirotomo ; Tsurusaki, Yoshinori ; Doi, Hiroshi ; Fukushima, Yoshimitsu ; Ikegawa, Shiro ; Yamada, Shuhei ; Sugahara, Kazuyuki ; Matsumoto, Naomichi. / Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome. In: Human Mutation. 2010 ; Vol. 31, No. 8. pp. 966-974.
@article{cb2234a6b9c44657b71fe75a32340059,
title = "Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome",
abstract = "Ehlers-Danlos syndrome (EDS) is a heterogeneous connective tissue disorder involving skin and joint laxity and tissue fragility. A new type of EDS, similar to kyphoscoliosis type but without lysyl hydroxylase deficiency, has been investigated. We have identified a homozygous CHST14 (carbohydrate sulfotransferase 14) mutation in the two familial cases and compound heterozygous mutations in four sporadic cases. CHST14 encodes dermatan 4-O-sulfotransferase 1 (D4ST1), which transfers active sulfate from 3′-phosphoadenosine 5′-phosphosulfate to position 4 of the N-acetyl-Dgalactosamine (GalNAc) residues of dermatan sulfate (DS). Transfection experiments of mutants and enzyme assays using fibroblast lysates of patients showed the loss of D4ST1 activity. CHST14 mutations altered the glycosaminoglycan (GAG) components in patients' fibroblasts. Interestingly, DS of decorin proteoglycan, a key regulator of collagen fibril assembly, was completely lost and replaced by chondroitin sulfate (CS) in the patients' fibroblasts, leading to decreased flexibility of GAG chains. The loss of the decorin DS proteoglycan due to CHST14 mutations may preclude proper collagen bundle formation or maintenance of collagen bundles while the sizes and shapes of collagen fibrils are unchanged as observed in the patients' dermal tissues. These findings indicate the important role of decorin DS in the extracellular matrix and a novel pathomechanism in EDS.",
author = "Noriko Miyake and Tomoki Kosho and Shuji Mizumoto and Tatsuya Furuichi and Atsushi Hatamochi and Yoji Nagashima and Eiichi Arai and Kazuo Takahashi and Rie Kawamura and Keiko Wakui and Jun Takahashi and Hiroyuki Kato and Hiroshi Yasui and Tadao Ishida and Hirofumi Ohashi and Gen Nishimura and Masaaki Shiina and Hirotomo Saitsu and Yoshinori Tsurusaki and Hiroshi Doi and Yoshimitsu Fukushima and Shiro Ikegawa and Shuhei Yamada and Kazuyuki Sugahara and Naomichi Matsumoto",
year = "2010",
month = "8",
day = "1",
doi = "10.1002/humu.21300",
language = "English",
volume = "31",
pages = "966--974",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "8",

}

Miyake, N, Kosho, T, Mizumoto, S, Furuichi, T, Hatamochi, A, Nagashima, Y, Arai, E, Takahashi, K, Kawamura, R, Wakui, K, Takahashi, J, Kato, H, Yasui, H, Ishida, T, Ohashi, H, Nishimura, G, Shiina, M, Saitsu, H, Tsurusaki, Y, Doi, H, Fukushima, Y, Ikegawa, S, Yamada, S, Sugahara, K & Matsumoto, N 2010, 'Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome', Human Mutation, vol. 31, no. 8, pp. 966-974. https://doi.org/10.1002/humu.21300

Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome. / Miyake, Noriko; Kosho, Tomoki; Mizumoto, Shuji; Furuichi, Tatsuya; Hatamochi, Atsushi; Nagashima, Yoji; Arai, Eiichi; Takahashi, Kazuo; Kawamura, Rie; Wakui, Keiko; Takahashi, Jun; Kato, Hiroyuki; Yasui, Hiroshi; Ishida, Tadao; Ohashi, Hirofumi; Nishimura, Gen; Shiina, Masaaki; Saitsu, Hirotomo; Tsurusaki, Yoshinori; Doi, Hiroshi; Fukushima, Yoshimitsu; Ikegawa, Shiro; Yamada, Shuhei; Sugahara, Kazuyuki; Matsumoto, Naomichi.

In: Human Mutation, Vol. 31, No. 8, 01.08.2010, p. 966-974.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome

AU - Miyake, Noriko

AU - Kosho, Tomoki

AU - Mizumoto, Shuji

AU - Furuichi, Tatsuya

AU - Hatamochi, Atsushi

AU - Nagashima, Yoji

AU - Arai, Eiichi

AU - Takahashi, Kazuo

AU - Kawamura, Rie

AU - Wakui, Keiko

AU - Takahashi, Jun

AU - Kato, Hiroyuki

AU - Yasui, Hiroshi

AU - Ishida, Tadao

AU - Ohashi, Hirofumi

AU - Nishimura, Gen

AU - Shiina, Masaaki

AU - Saitsu, Hirotomo

AU - Tsurusaki, Yoshinori

AU - Doi, Hiroshi

AU - Fukushima, Yoshimitsu

AU - Ikegawa, Shiro

AU - Yamada, Shuhei

AU - Sugahara, Kazuyuki

AU - Matsumoto, Naomichi

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Ehlers-Danlos syndrome (EDS) is a heterogeneous connective tissue disorder involving skin and joint laxity and tissue fragility. A new type of EDS, similar to kyphoscoliosis type but without lysyl hydroxylase deficiency, has been investigated. We have identified a homozygous CHST14 (carbohydrate sulfotransferase 14) mutation in the two familial cases and compound heterozygous mutations in four sporadic cases. CHST14 encodes dermatan 4-O-sulfotransferase 1 (D4ST1), which transfers active sulfate from 3′-phosphoadenosine 5′-phosphosulfate to position 4 of the N-acetyl-Dgalactosamine (GalNAc) residues of dermatan sulfate (DS). Transfection experiments of mutants and enzyme assays using fibroblast lysates of patients showed the loss of D4ST1 activity. CHST14 mutations altered the glycosaminoglycan (GAG) components in patients' fibroblasts. Interestingly, DS of decorin proteoglycan, a key regulator of collagen fibril assembly, was completely lost and replaced by chondroitin sulfate (CS) in the patients' fibroblasts, leading to decreased flexibility of GAG chains. The loss of the decorin DS proteoglycan due to CHST14 mutations may preclude proper collagen bundle formation or maintenance of collagen bundles while the sizes and shapes of collagen fibrils are unchanged as observed in the patients' dermal tissues. These findings indicate the important role of decorin DS in the extracellular matrix and a novel pathomechanism in EDS.

AB - Ehlers-Danlos syndrome (EDS) is a heterogeneous connective tissue disorder involving skin and joint laxity and tissue fragility. A new type of EDS, similar to kyphoscoliosis type but without lysyl hydroxylase deficiency, has been investigated. We have identified a homozygous CHST14 (carbohydrate sulfotransferase 14) mutation in the two familial cases and compound heterozygous mutations in four sporadic cases. CHST14 encodes dermatan 4-O-sulfotransferase 1 (D4ST1), which transfers active sulfate from 3′-phosphoadenosine 5′-phosphosulfate to position 4 of the N-acetyl-Dgalactosamine (GalNAc) residues of dermatan sulfate (DS). Transfection experiments of mutants and enzyme assays using fibroblast lysates of patients showed the loss of D4ST1 activity. CHST14 mutations altered the glycosaminoglycan (GAG) components in patients' fibroblasts. Interestingly, DS of decorin proteoglycan, a key regulator of collagen fibril assembly, was completely lost and replaced by chondroitin sulfate (CS) in the patients' fibroblasts, leading to decreased flexibility of GAG chains. The loss of the decorin DS proteoglycan due to CHST14 mutations may preclude proper collagen bundle formation or maintenance of collagen bundles while the sizes and shapes of collagen fibrils are unchanged as observed in the patients' dermal tissues. These findings indicate the important role of decorin DS in the extracellular matrix and a novel pathomechanism in EDS.

UR - http://www.scopus.com/inward/record.url?scp=77955073599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955073599&partnerID=8YFLogxK

U2 - 10.1002/humu.21300

DO - 10.1002/humu.21300

M3 - Article

C2 - 20533528

AN - SCOPUS:77955073599

VL - 31

SP - 966

EP - 974

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 8

ER -

Miyake N, Kosho T, Mizumoto S, Furuichi T, Hatamochi A, Nagashima Y et al. Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome. Human Mutation. 2010 Aug 1;31(8):966-974. https://doi.org/10.1002/humu.21300